VOLMAX 8mg price in UAE

Overview

Welcome to Dwaey, specifically on VOLMAX 8mg Tablets/Controlled Release page.
This medicine contains an important and useful components, as it consists of Salbutamol (as sulfate).
VOLMAX 8mg is available in the market in concentration 8mg/Tablet and in the form of Tablets/Controlled Release.

GLAXO WELLCOME GmbH & CO. is the producer of VOLMAX 8mg and it is imported from GERMANY, The most popular alternatives of VOLMAX 8mg are listed downward .

Mode Of Action

Salbutamol is a direct-acting sympathomimetic with beta-adrenergic activity and selective action on ?2 receptors, producing bronchodilating effects. It also decreases uterine contractility.

Indication

Acute severe asthma
Severe bronchospasm

Precaution

Hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to QT-interval prolongation, HTN, DM, glaucoma, hypokalaemia, seizure disorder. Renal impairment. Elderly. Pregnancy and lactation. Monitoring Parameters Monitor BP, heart rate, electrolyte and fluid balance; glucose, lactate and K levels. Lactation: Unknown whether drug is excreted in milk; not recommended

Side Effects

>10% Tremor (20%)
Nervousness in children aged 2-6 years (20%)
Insomnia in children aged 6-12 years receiving 4-12 mg q12hr (11%) 1-10% Nausea (10%)
Fever (1.6-9%)
Bronchospasm (8%)
Vomiting (7%)
Headache (4-7%)
Dizziness (1-7%)
Cough (5%)
Allergic reactions (4%)
Otitis media (3.3%)
Epistaxis in children (3%)
Increased appetite (3%)
Urinary tract infection (3%)
Dry mouth (<3%)
Eructation or flatulence (<3%)
Increased sweating (<3%)
Pain (2.7%)
Dyspepsia (1-2%)
Hyperactivity (1-2%)
Chills (<2%)
Lymphadenopathy (<2%)
Ocular pruritus (<2%)
Sweating (<2%)
Conjunctivitis in children aged 2-6 years (1%)
Dysphonia (>1%)
Flu syndrome
Nervousness <1% Epigastric pain
Epistaxis in adults
Hyperactivity in children Frequency Not Defined Adverse reactions such as hypertension
angina
vertigo
central nervous system stimulation
insomnia
headache
metabolic acidosis
and drying or irritation of oropharynx Hypersensitivity
Hypokalemia
Increased blood glucose levels
Prolonged QT interval and ST-segment depression
Sleeplessness
Tachycardia (incidence varies with formulation) Urticaria
angioedema
rash
bronchospasm
and oropharyngeal edema (rare) Potentially Fatal: Potentially serious hypokalaemia after large doses.

Contra indication

Salbuatmol inhaler is contraindicated in patients with a history of hypersensitivity to any of its components. Although intravenous Salbutamol, and occasionally Salbutamol tablets, is used in the management of premature labour uncomplicated by conditions such as placenta praevia, ante-partum haemorrhage or toxaemia of pregnancy, Salbutamol inhaler preparations are not appropriate for managing premature labour. Salbutamol preparation should not be used for threatened abortion during the first or second trimesters of pregnancy.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Diuretics, corticosteroids and xanthines may augment hypokalaemia. CV effects potentiated by MAOIs, TCAs, sympathomimetics. Increases absorption of sulfamethoxazole when used together. May markedly increase heart rate and BP when used with atomoxetine. Reduces serum levels of digoxin. Hypokalaemia induced by salbutamol increases the risk of digitalis toxicity. BP should be closely monitored if linezolid is used concurrently with salbutamol.